SENS 8-K 2026-11-09
Senseonics Holdings, Inc. (SENS) 8-K dated 2026-11-09 — accession 0001104659-26-124500.
Senseonics Holdings, Inc. (SENS) is a medical devices company listed on NASDAQ.
SENS: Senseonics Holdings, Inc. Reports Third Quarter 2026 Financial Results
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported SENS revenue for 2025-12-31 was $35.3M. Net income was -$69.1M. Revenue was up 56.9% from 2024-12-31 to 2025-12-31. SENS currently screens at market cap $377.4M.
Not investment advice. The SENS SEC hub lists recent forms. The stock page is the research view.
- Guidance
- full-year 2026 revenue guidance to $68 million to $70 million from $62 million to $66 million, representing year-over-year growth
Why it matters
- full-year 2026 revenue guidance to $68 million to $70 million from $62 million to $66 million, representing year-over-year growth
- Our approximately 140% year-over-year revenue growth in Q3 reflects the progress we are making in executing our commercial strategy and driving increased awa…